New hope for hard-to-treat leukaemias? early trial of LBS-007 begins
Disease control
Recruiting now
This study tests a new drug called LBS-007 in adults with acute leukaemia (AML or ALL) that has returned or not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it helps control the disease. About 90 participants will…
Phase: PHASE1, PHASE2 • Sponsor: Lin BioScience, Inc • Aim: Disease control
Last updated May 04, 2026 16:23 UTC